IM
Cambridge Medical Technologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Platform Development | Continuous biomarker monitoring for chronic diseases (e.g., diabetes, anticoagulation) | Pre-clinical |
Leadership Team at Cambridge Medical Technologies
ML
Michael Lacey-Solymar
Chairman
JJ
Jack Jachmann
Chief Executive Officer
JC
James Cooke
Chief Financial Officer
JC
John Currie
Chief Scientist
JW
John Wensman
VP - Research & Product Development
JW
Joe Weber
VP, Strategy & Business Development
SM
Steve Mulhall
VP, Operations
AM
Alex Moseley
VP, Clinical Programs
HS
Helena Snyder
VP, Electrochemistry